Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Robert Paul Hasserjian, M.D.


This page shows the publications co-authored by Robert Hasserjian and Paola Dal Cin.
Connection Strength

  1. Deletion of chromosome 20q: friend or foe? Leuk Res. 2011 Jul; 35(7):844-5.
    View in: PubMed
    Score: 0.480
  2. Composite chronic myeloid leukemia and essential thrombocythemia with BCR-ABL1 fusion and CALR mutation. Am J Hematol. 2019 04; 94(4):504-505.
    View in: PubMed
    Score: 0.200
  3. Ring chromosome in myeloid neoplasms is associated with complex karyotype and disease progression. Hum Pathol. 2017 10; 68:40-46.
    View in: PubMed
    Score: 0.186
  4. Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts. Mod Pathol. 2016 10; 29(10):1221-31.
    View in: PubMed
    Score: 0.172
  5. Routine conventional karyotyping of lymphoma staging bone marrow samples does not contribute clinically relevant information. Am J Hematol. 2015 Jun; 90(6):529-33.
    View in: PubMed
    Score: 0.158
  6. High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome. Mod Pathol. 2015 Apr; 28(4):552-63.
    View in: PubMed
    Score: 0.153
  7. Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica. 2011 Aug; 96(8):1144-52.
    View in: PubMed
    Score: 0.120
  8. Identification of del(20q) in a subset of patients diagnosed with idiopathic thrombocytopenic purpura. Br J Haematol. 2009 Mar; 144(5):800-2.
    View in: PubMed
    Score: 0.101
  9. Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol. 2007 Apr; 127(4):642-50.
    View in: PubMed
    Score: 0.090
  10. Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells. Haematologica. 2021 02 01; 106(2):555-564.
    View in: PubMed
    Score: 0.059
  11. High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia. Am J Hematol. 2019 08; 94(8):921-928.
    View in: PubMed
    Score: 0.053
  12. Clinicopathologic evaluation of cytopenic patients with isolated trisomy 8: a detailed comparison between idiopathic cytopenia of unknown significance and low-grade myelodysplastic syndrome. Leuk Lymphoma. 2017 03; 58(3):569-577.
    View in: PubMed
    Score: 0.043
  13. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Mod Pathol. 2016 08; 29(8):854-64.
    View in: PubMed
    Score: 0.042
  14. Acute myeloid leukemia in a patient with constitutional 47,XXY karyotype. Leuk Res Rep. 2015; 4(1):28-30.
    View in: PubMed
    Score: 0.039
  15. A unique PML-RARa rearrangement involving chromosomes 11, 15, and 17 in a patient with acute promyelocytic leukemia. Exp Hematol. 2013 Sep; 41(9):769-71.
    View in: PubMed
    Score: 0.034
  16. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol. 2010 Mar; 34(3):327-40.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.